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Background: Psoas muscle abscess is a previously rare disease that has increased in its reported preva-
lence because of improved diagnostic tools. The literature on psoas muscle abscess mostly consists of
case reports and case series.
Methods: We analyzed medical records, such as characteristics, pathogens, and disease pattern, from our
hospital in the past 8 years and report nine cases of psoas abscess. We also reviewed the literature for
case series and performed a meta-analysis to assess the current characteristics of this disease since 1986.
Results: We reviewed a total of 36 studies, with a total of 682 cases. The average age was 52.6 years, and
the mortality rate was 8% (55 of 682). In 35 studies, a total of 274 cases (40.77%) received drainage (274 of
672), whereas 290 (43.15%) received surgery. In 522 cases, the ratio of primary to secondary etiologies
was 1:1.71. In 209 cases, Staphylococcus aureus, and in 70 cases, Escherichia coli were identiﬁed as the
pathogens from culture data. Compared with Ricci’s case series, we found an obvious increase in prev-
alence of secondary causes (63.2% compared with 21.8%) and higher mortality in recent study (6.7% in
Ricci’s study and 8.1% in recent study). There was an obvious shift toward drainage as the treatment of
choice.
Conclusions: We conclude that a higher mortality has occurred in recent study, and psoas abscess is an
infrequent and easily overlooked infectious disease requiring early diagnosis with favorable results with
percutaneous drainage.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Since the ﬁrst report of acute inﬂammation of the psoas muscle
in the literature by Mynter in 18811, psoas muscle abscess has
been known as an infrequent, insidious, yet easily overlooked and
potentially life-threatening infectious disease. Psoas muscle infec-
tion was once in common coexistence with tuberculosis spine
infection, but the incidence decreased with the widespread use
of standard antituberculosis medications, and pyogenic causes
became predominant. The incidence has increased because of the
reﬁnement of diagnostic tools, such as widespread use of
computerized tomography (CT), but the condition is still regarded
as a rare disease even in recent studies2.edicine, National Yang-Ming
26042, Taiwan, Republic of
erest.
this article. They contributed
iwan Society of Geriatric EmergenPrevious reports of psoas abscess in the medical literature
consist of case reports and case series with small case numbers.
Ricci et al3 presented a case series with a case number of 367 in
1986, the largest number of cases so far, which included every case
published in the literature at that time3. Since then, there has been
no similar large, worldwide multicenter case review of psoas
abscess, and only case series and reports of various sizes exist.
Recently, a comprehensive retrospective case series by Navarro
López et al2 consisted of 124 cases from 11 hospitals in Spain, the
largest case number since the report by Ricci3. Much has changed
since 1986, regarding mortality, diagnostic approach, treatment
modalities, and aspects of the disease. In view of the aforemen-
tioned point, we sought to conduct an extensive review of the
medical literature containing case series after the year 1986 and to
examine the current features of the disease. In addition, we
included the data from the past 8 years from our institute records.
We assessed the pooled data and checked the mortality, gender
difference, and age distribution, and discuss in detail specially
designed reports. Our study provides an updated evaluation of
pooled data of worldwide cases of psoas abscess and may shedcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Y.-C. Lai et al76some light on the current status of the disease and its treatment
options.
2. Materials and Methods
2.1. Case records from our institution
From January 2002 to May 2009, nine patients with acute
pyogenic psoas abscess were diagnosed according to the medical
records database in our hospital. The patient was diagnosed of
psoas muscle abscess if one or more of the following was present:
(1) clinical presentation of infection with compatible CT ﬁnding of
abscess in the iliopsoas muscle; (2) percutaneous or surgical
drainage proven abscess accumulation at the psoas muscle area. No
coexisting tuberculous infection or Cohn’s disease was present in
any of the cases. The clinical presentation, etiology, location,
microbiology, treatment, and outcome were analyzed. We assessed
the presence of common risk factors for acute psoas muscle
abscess, including old age, sex, diabetes mellitus, hypertension,
and other coexisting medical problems. The presence of urinary
tract infection was checked. The results are summarized in
Table 1.
2.2. Review methods
A search of the PubMed database from 1986 to the present was
performed, using the Boolean expression [(Psoas or iliopsoas) and
(abscess)]. We excluded single case reports and cases with patients
younger than 18 years. We included case series in English language,
and case series with non-English language were only included
when the information of interest could be derived from the abstract
or from the manuscript itself. Because of different characteristics
and aspects of interests of each individual case series, we only
examined features that were demonstrated in all of the series,
including average age, sex distribution, treatment modality
(surgical vs. percutaneous vs. antibiotics only), mortality. We dis-
cussed case series with special features. The result is summarized in
Table 2.
Psoas abscess was classiﬁed as primary or secondary. Primary
psoas abscesses lacked a deﬁnite source of infection4. On the
contrary, secondary psoas abscesses are identiﬁed with an infec-
tious source that may result from direct invasion of nearby
infectious site with predisposing by trauma or operation.
3. Results
3.1. Case records from our institution
A review of the medical records database of our hospital
revealed nine patients with 11 episodes of radiography- or
drainage-conﬁrmed pyogenic psoas abscess. Two patients had
a second episode of psoas abscess; recurrence was assumed in one
patient as the second episode occurred 1 month after discharge,
and culture data yielded same bacteria results. In the other patient
with a second event, the two episodes were 6 months apart, and
different locations were noted. The ﬁrst episode was presumed to
be secondary to urinary tract infection, whereas the second episode
was presumed as primary psoas abscess. For calculation purposes,
separate episodes in the same patient were calculated separately.
An analysis of the characteristics in the 11 episodes revealed
the following: average age was 60.6 years on presentation, the
male:female sex ratio was 1:1.75, and the average length of stay
was 25.7 days. Five episodes were classiﬁed as primary if an origin
of infectious source could not be located, whereas six episodeswere
secondary, all presenting with urinary tract infection. The most
Table 2
Characteristics of care seriesemeta-analysis
Study No. of
cases
Sex Mortality (n) Average
age (yr)
Drainage (n) Surgery (n) S aureus (n) E coli (n) Primary (n) Secondary (n) Duration of case
enrollment
Male (n) Female (n)
Lai et ala 11 4 7 1 60.6 8 1 3 2 5 6 2002e2009
Al-Hilli et al, Ir Med J6 3 3 0 0 59 3 1 NA NA 2 1 NA
Dauchy et al, Acta Orthop7 13 9 4 0 70 6 4 5 NA 0 7 2005/1/1e2006/12/31
Kaya and Sayil, Trop Doct8 2 1 1 0 48 1 0 NA NA 0 2 NA
Navarro López, Medicine (Baltimore)2 124 86 38 6 58 63 21 23 23 27 97 1990e2004
Charalampopoulos et al, Scand J Gastroenterol9 5 4 1 1 70 4 1 2 1 3 2 NA
Yacoub et al, Am J Surg10 41 30 11 0 44 26 2 11 NA 18 23 2000e2006
Yadav et al, Kathmandu Univ Med J11 36 22 14 1 24.33 0 36 24 NA NA NA 2005/2e2006/3
Kofﬁ et al, West Afr J Med12 18 8 10 0 35.7 2 16 2 3 15 3 NA
Hammami et al, Tunis Med13 38 22 16 1 44 16 9 10 2 10 28 1990/1e2005/12
Hsu and Lin, J Vasc Surg14 8 7 1 6 71 0 7 3 2 0 8 1996e2007
Tofuku et al, Spine15 12 9 3 1 73.5 12 0 NA NA 0 12 2003/3e2005/7
Garner et al, Colorectal Dis16 15 8 7 0 57 13 0 4 2 6 9 2002/2e2005
Audia et al, Rev Med Interne17 6 3 3 0 60 3 1 NA NA 0 6 NA
Pérez-Fernández et al, Enferm Infecc Microbiol Clin18 14 10 4 0 42 8 4 3 3 0 14 1999e2004
Loussaïef et al, Tunis Med19 11 8 3 0 27 5 1 6 NA NA NA NA
Hanaoka et al, J Neurosurg Spine20 5 5 0 0 76 4 1 2 NA 0 5 2002e2004
Baier et al, Langenbecks Arch Surg21 40 19 21 6 54.3 8 32 12 7 10 30 NA
Van den Berge M et al, Neth J Med22 12 5 7 2 55 1 6 6 2 5 7 2001/6e2004/6
Cánovas Ivorra et al, Arch Esp Urol23 5 4 1 0 48.2 4 0 4 NA 5 0 1985e2000
Hamano et al, Urol Int24 17 11 6 3 66.2 3 13 6 3 8 9 1995e2001
Penado et al, Enferm Infecc Microbiol Clin26 23 16 7 4 NA 7 9 NA NA NA NA NA
Afaq et al, Trop Doct5 72 NA NA 0 NA 0 72 45 NA NA NA NA
Melissas et al, Acta Chir Belg25 3 2 1 0 43.5 0 3 2 NA 3 0 NA
Dahami et al, Ann Urol Paris27 18 11 7 1 35 4 15 10 2 18 0 1990e2004
Chang et al, J Microbiol Immunol Infect28 15 8 7 4 53.8 10 5 NA NA 0 15 1995/7e1999/12
Oliver et al, Clin Microbiol Infect31 2 1 1 0 63 1 1 NA NA 6 5 1998
Huang et al, J Infect29 25 7 18 11 64 15 5 4 11 6 19 1988/8e1998/7
Lin et al, J Microbiol Immunol Infect32 29 17 12 2 60.3 14 7 10 5 18 11 1993e1998
Lee et al, J Microbiol Immunol Infect30 11 3 8 2 53.8 9 2 3 1 6 5 1988/1e1998/5
El Hassani et al, Rev Rhum Engl Ed33 16 14 2 0 NA 6 10 7 1 16 0 1987e1997
Laguna and Moya, Enferm Infecc Microbiol Clin34 11 NA NA 1 NA 5 3 2 NA 5 6 1983e1996
Blanco, An Med Interna35 6 1 5 0 65.8 NA NA NA NA NA NA NA
Chern et al, Am J Emerg Med36 10 8 2 2 64.6 10 2 NA NA NA NA 1993e11/1994/10
Thomas et al, Br J Urol37 5 5 0 0 NA 3 0 NA NA NA NA NA
Total 682 371 228 55 52.59 274 290 209 70 192 330 NA
E coli¼ Escherichia coli; NA¼ not available; No.¼ number; S aureus¼ Staphylococcus aureus.
a Unpublished data; please refer Table 1.
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Y.-C. Lai et al78common comorbidity was diabetes, present in four out of nine
patients (44.4%). Of the 11 episodes, two were bilateral (22%), with
a right:left ratio of 2:1 in the other unilateral episodes. The leading
microbiology agent was methicillin-susceptible Staphylococcus
aureus (27%), and Escherichia coli was the second (18%). In two
episodes, no culture data could be obtained from blood, urine, or
drainage samples, if performed. One case underwent surgery,
whereas in six episodes, drainage was performed.
In our series, only one mortality case (Patient 5, Table 1) was
reported out of 11 episodes (9%). The patient had an underlying
history of diabetes, hypertension, and autoimmune hepatitis,
which required her to undergo long-term usage of oral steroids
(prednisone 20 mg daily, for more than 10 years). She presented
with psoas abscess secondary to urinary tract infection. Empirical
antibiotics were initially chosen with ceftazidime, (2 g every
12 hours) to cover fulminant urinary tract pathogens. The patient
soon progressed to widespread intra-abdominal infection, which
led to respiratory failure and intensive care unit admission. The
antibiotics were replaced with imipenem–cilastin (500 mg every
8 hours) for broad-range coverage. Blood culture data revealed
infection by Salmonella typhi; however, she completed the treat-
ment course with imipenemecilastatin. Her condition deteriorated
and ultimately expired because of profound septic shock despite
intensive care. On retrospective, the immunocompromised status
and inadequate coverage of antibiotics (as S typhi is ideally treated
with either ciproﬂoxacin or ceftriaxone as ﬁrst choice) might
account for poor response to bacterial infection andmay contribute
to her fatal outcome.
3.2. Review of the literature
We reviewed case series and reports consisting more than one
case of psoas abscess reported in PubMed after the year 1986. An
initial search of the literature reviewed 51 studies meeting our
criteria. We excluded cases consisting of patients younger than 18
years and cases in non-English literature for which details could not
be retrieved from either the abstract or the manuscript. We
included our institution data from the past 8 years and assessed the
cumulative data of the studies. The results consisted of 36 studies,
with a total of 682 cases2,5e37. The gender distribution was 1.62:1,
which consisted of 371 males and 228 females in 34 studies from
which the information could be obtained. The average age was
52.59 years in 555 cases. The mortality rate was 8% (55 of 682). In
35 studies, a total of 274 cases (40.77%) received drainage (274 of
672), whereas 290 (43.15%) received surgery. In 522 cases, there
were 192 primary cases, with 330 secondary cases (primary:
secondary, 1:1.71). In two hundred nine cases, S aureus, and in 70
cases, E coli were identiﬁed as the caustic microorganisms from
culture data.
To analyze the change in characteristics since Ricci’s case series3
in 1986, we compared their results with our pooled data (Table 3).
We found an obvious increase in the prevalence of secondary
causes (63.2% compared with 21.8%). The mortality rate was higher
in a recent study (6.7% in Ricci’s studyand 8.1% in the recent study).Table 3
Comparison of characteristics between Ricci’s study and our meta-analysis
Study No. of
cases
Sex Mortality Average
age (yr)
Male Female
Ricci et al (1986)3 367 251 (66.5) 116 (33.5) 24 (6.7) NA
Case series (1986epresent)a 682 371 (54.4) 228 (45.6) 55 (8.1) 52.59
E coli¼ Escherichia coli; NA¼ not available; No.¼ number; S aureus¼ Staphylococcus aur
Data are represented as n (%).
a Unpublished data; please refer Table 2.There was an obvious shift toward drainage as the treatment of
choice. Other data are summarized in Table 3.
4. Discussion
Since the study by Ricci et al3 in 1986, more than 1000 cases
have been reported in the medical literature. The mortality of this
disease showed a wide variation among different reports, with the
highest being 44% in one case series29, and several case series
showed zero mortality10,12,16. The statistical signiﬁcance was
limited because of insufﬁcient sample size in most of the reports. In
larger series, the mortality was 4.8% in Navarro López et al’s series2
and 0% in Afaq et al’s series5. In our study, the pooled data showed
a mortality rate of 8%, proving that a lowmortality can be achieved
with current diagnostic and therapeutic techniques.
In the pooled data, 40.77% received percutaneous drainage, and
43.15% received surgical drainage. This demonstrates a vast differ-
ence from the study by Ricci in 19863, inwhich surgical incision and
drainage were selected as the therapeutic option in 78% (257 of
327). The consensus has shifted to advocate nonsurgical approach
as an initial treatment with satisfactory results2,10,38, consistent
with our ﬁndings. Compared with Ricci’s study3, there was an
increased prevalence of secondary causes. This can be explained by
improved diagnostic technique and the recent widespread use of
CT. Surprisingly, there was a higher mortality rate (8.1%) despite
obvious improvement in medicine than that in Ricci’s study3 (6.7%).
The explanation may be the emergence of more virulent multi-
resistant bacteria and the higher prevalence of secondary causes,
which imply a very virulent primary source. Further studies may be
needed to validify this result.
An interesting case series was the study by Afaq et al5, including
72 cases in which all of them received surgery as ﬁrst-line treat-
ment for psoas muscle abscess, with no mortalities reported. The
authors pointed out that surgery was relatively inexpensive
(approximately 40 US dollars per operation) in Nepal and carried
a safe proﬁle. Another series from the same region also consisted
of surgical drainage as the ﬁrst-line treatment11 and advocated
a standardized doctrine of surgical approach primarily. Because of
differences in cost, availability, practice guidelines, and health care
policies in individual countries, the practicability of the conclusion
in this study remains to be veriﬁed.
The microbiological distribution is of great clinical interest, and
we tried our best to reproduce the exact results of each study.
However, in several studies, the exact percentage of each culture
result was not known. In most studies, excluding studies primed
toward speciﬁc microbiology agents, S aureus still predominated in
primary causes, whereas E coli was the leading agent in secondary
causes, presumptively related to high incidence of urinary tract
infection in this situation. This ﬁnding was not contrary to that of
Ricci’s original study3. A remarkable feature was the high mortality
rate in two series from Taiwan28,29, both showing a high prevalence
of Klebsiella pneumoniae (24% and 100%) and high mortality (44%
and 26%). Klebsiella pneumoniae, a frequent infection agent in
Orientals and identiﬁed as the endemic microbial agent causingDrainage (n) Surgery (n) S aureus (n) E coli (n) Primary Secondary
24 328 NA NA 287 (78.2) 90 (21.8)
274 290 209 70 192 (36.8) 330 (63.2)
eus.
An Update on Psoas Muscle Abscess 79serious morbidity in Taiwan28, was proposed as an independent
factor for mortality in psoas abscess27. This ﬁnding remains to be
validated in further studies.
Our review consisted of case series only, and solitary case
reports were excluded from our review. The reason for the study
design was that case reports usually reﬂect a special circumstance
or unusual coexisting feature and might not be representative of
the generalized clinical picture. Case series, on the other hand,
reﬂects a systemic tracking of a cumulative period of time and in
itself carries a certain degree of unbiased randomness. The pooled
data revealed results relatively consistent with the large case series
by Navarro López et al2 and may serve as a statistically signiﬁcant
reﬂection for the current clinical features and treatment of psoas
abscess. This meta-analysis provides several important conclusions.
First of all, the predominant treatment option has leaned toward
nonsurgical drainage primarily since 1986, and the pooled
mortality results seem noninferior. The reports from Nepal reﬂect
a distinct approach because of its speciﬁc medical environment and
economical issues. Furthermore, secondary causes of psoas abscess
have increased in prevalence in comparison with those of Ricci’s
study, probably because of improved diagnostic modalities and
physician awareness38. Staphylococcus aureus and E coli remain the
leading microbial agents, serving as further reference for antibiotic
selection. The low mortality rate may conﬁrm the notion that
medical treatment with antibiotics and drainage alone is a reason-
able choice for psoas abscess.
Our review is prone to several weaknesses. The pooled data
consisted of retrospective data only, and no prospective study was
performed, diminishing their evidence level. The difﬁculty in per-
forming a prospective investigation lies in the low prevalence of
this disease. Several case series failed to report every parameter of
interest, thus causing possible inaccuracies in the pooled data
analysis. Several articles were non-English, thus hindering our data
collection. Nonetheless, the case number of the pooled data serves
as statistical strength and may serve as a substantial reference
value for further clinical practice and investigations.
In conclusion, we reported nine cases from our hospital records
in the past 8 years; additionally, we reviewed the literature and
pooled 36 case series with a total of 678 cases to conclude an
updated result of psoas abscess. The average mortality from the
pooled datawas 8%. The primary approach chosen for psoas abscess
is favored as percutaneous drainage. Signiﬁcant differences in
microbiological characteristics and therapeutic modalities were
demonstrated in comparison with those of Ricci’s study in 1986.
Psoas abscess is an infrequent and easily overlooked infectious
disease requiring early diagnosis, and current treatment options
using percutaneous drainage may provide favorable results.References
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